SCHEMBL4989486

SCHEMBL4989486

Cc1ccc(C(c2cc[c]cc2)c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
ACHE P22303 1/20 0.40
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
CFTR P13569 1/20 0.36
GOPC Q9HD26 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
HPGD P15428 1/20 0.35
CHRNA7 P36544 1/20 0.35
GAA P10253 2/20 0.35
MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10839213 0.87 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3TSHRCFTR
SCHEMBL3840843 0.87 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3TSHRCFTR
SCHEMBL60997 0.87 LMNA (0.53) LMNASLC6A2SLC6A4SLC6A3TSHR
SCHEMBL3657920 0.87 LMNA (0.53) LMNASLC6A2SLC6A4SLC6A3TSHR
Methane SCHEMBL11860709 0.84 LMNA (0.50) LMNASLC6A2SLC6A4SLC6A3TSHR
Toluene SCHEMBL28096640 0.79 LMNA (0.65) LMNASLC6A2SLC6A4SLC6A3TSHR
P-Xylene SCHEMBL28097208 0.77 ACHE (0.61) LMNATSHRALOX12ACHESMN1; SMN2
SCHEMBL10452706 0.77 CYP19A1 (0.50) LMNASLC6A2SLC6A4SLC6A3TSHR
SCHEMBL122911 0.76 ACHE (0.57) LMNATSHRALOX12ACHEMAPT
SCHEMBL5249727 0.76 SLC6A2 (0.33) SLC6A2SLC6A4SLC6A3CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108790-A1 S-Alkyl-Sulphenyl Protection Groups in Solid-Phase Synthesis LONZA AG (CH) 2008-05-08 US disclosed
EP-1807442-A1 S-ALKYL-SULPHENYL PROTECTION GROUPS IN SOLID-PHASE SYNTHESIS LONZA AG (CH) 2007-07-18 EP disclosed
WO-2006045603-A1 S-ALKYL-SULPHENYL PROTECTION GROUPS IN SOLID-PHASE SYNTHESIS LONZA AG (CH) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108790-A1 S-Alkyl-Sulphenyl Protection Groups in Solid-Phase Synthesis PTMS, SCLY, STS LMNA 1469/4885SLC6A2 3277/4885SLC6A4 2979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.